4.6 Article

Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii Shows a Protective Effect on DNBS and DSS-Induced Colitis Model in Mice through Inhibition of NF-κB Pathway

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Experimental Models of Inflammatory Bowel Diseases

Patricia Kiesler et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)

Review Microbiology

Faecalibacterium prausnitzii and human intestinal health

S. Miquel et al.

CURRENT OPINION IN MICROBIOLOGY (2013)

Article Immunology

A NOVEL INTERLEUKIN-10 DNA MUCOSAL DELIVERY SYSTEM ATTENUATES INTESTINAL INFLAMMATION IN A MOUSE MODEL

S. Del Carmen et al.

EUROPEAN JOURNAL OF INFLAMMATION (2013)

Article Multidisciplinary Sciences

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

June L. Round et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Biochemistry & Molecular Biology

Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria

Ivaylo I. Ivanov et al.

Article Biochemistry & Molecular Biology

In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells

J-M Chatel et al.

GENE THERAPY (2008)

Article Multidisciplinary Sciences

A microbial symbiosis factor prevents intestinal inflammatory disease

Sarkis K. Mazmanian et al.

NATURE (2008)

Article Multidisciplinary Sciences

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Harry Sokol et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)